Use of galantamine to treat vascular dementia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  2002-11-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(02)11450-4PMID 12433549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.

  2002cited by this paper
• Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow‐up

  2001cited by this paper
• An efficacy and safety analysis of Exelon® in Alzheimer’s disease patients with concurrent vascular risk factors

  2000cited by this paper
• Selectivity of Cholinesterase Inhibition

  1999cited by this paper

• AN OVERVIEW ON “MEMORY DYSFUNCTION, TYPES OF MEMORY, AND ITS CLINICAL DISORDERS”

  2016cites this paper
• Memory Dysfunction in Dementia

  2011cites this paper
• Understanding Memory Dysfunction

  2009cites this paper
• Galantamine for Alzheimer's disease and mild cognitive impairment.

  2006cites this paper
• Memory dysfunction.

  2005cites this paper
• current concepts Memory Dysfunction

  2005cites this paper
• Galantamine for Alzheimer's disease.

  2004cites this paper
• Galantamine: use in Alzheimer’s disease and related disorders

  2004cites this paper
• Galantamine for Alzheimer's disease.

  2004cites this paper
• Treatment of dementia with neurotransmission modulation

  2003cites this paper